Medication Update

The Nurse Practitioner: The American Journal of Primary Health Care
January 2013 
Volume 38  Number 1
Pages 56 - 56
  PDF Version Available!

Janssen Pharmaceuticals, Inc. has received approval for an additional indication for tapentadol extended release oral tablets (Nucynta ER).The tablets manage neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.Nucynta ER is a centrally acting synthetic analgesic and is the first and only opioid approved by the FDA for neuropathic pain associated with DPN.The most common adverse reactions associated with the medication in clinical trials are nausea, constipation, vomiting, dizziness, headache, and somnolence.Nucynta ER labeling contains a warning about abuse potential, life-threatening respiratory depression, accidental exposure, and interaction with alcohol. Consult product labeling for important prescribing information and contraindications.Abbott's adalimumab (Humira) is now indicated for the treatment of adult patients with moderate-to-severe ulcerative colitis (UC)

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

What internal motivators drive RNs to pursue a BSN?
Nursing2014 , October 2014
Free access will expire on November 24, 2014.

Breast Cancer Risk Assessment in Primary Care
MCN, The American Journal of Maternal/Child Nursing, September/October 2014
Free access will expire on November 10, 2014.

Nurses spurring innovation
Nursing Management, October 2014
Free access will expire on November 10, 2014.

More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events